Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtrer
Plus de filtres










Base de données
Gamme d'année
1.
Int J Mol Sci ; 23(3)2022 Jan 24.
Article de Anglais | MEDLINE | ID: mdl-35163201

RÉSUMÉ

Central serous chorioretinopathy (CSCR) is a retinal disease affecting the retinal pigment epithelium (RPE) and the choroid. This is a recognized side-effect of glucocorticoids (GCs), administered through nasal, articular, oral and dermal routes. However, CSCR does not occur after intraocular GCs administration, suggesting that a hypothalamic-pituitary-adrenal axis (HPA) brake could play a role in the mechanistic link between CSCR and GS. The aim of this study was to explore this hypothesis. To induce HPA brake, Lewis rats received a systemic injection of dexamethasone daily for five days. Control rats received saline injections. Baseline levels of corticosterone were measured by Elisa at baseline and at 5 days in the serum and the ocular media and dexamethasone levels were measured at 5 days in the serum and ocular media. The expression of genes encoding glucocorticoid receptor (GR), mineralocorticoid receptors (MR), and the 11 beta hydroxysteroid dehydrogenase (HSD) enzymes 1 and 2 were quantified in the neural retina and in RPE/ choroid. The expression of MR target genes was quantified in the retina (Scnn1A (encoding ENac-α, Kir4.1 and Aqp4) and in the RPE/choroid (Shroom 2, Ngal, Mmp9 and Omg, Ptx3, Plaur and Fosl-1). Only 10% of the corticosterone serum concentration was measured in the ocular media. Corticosterone levels in the serum and in the ocular media dropped after 5 days of dexamethasone systemic treatment, reflecting HPA axis brake. Whilst both GR and MR were downregulated in the retina without MR/GR imbalance, in the RPE/choroid, both MR/GR and 11ß-hsd2/11ß-hsd1 ratio increased, indicating MR pathway activation. MR-target genes were upregulated in the RPE/ choroid but not in the retina. The psychological stress induced by the repeated injection of saline also induced HPA axis brake with a trend towards MR pathway activation in RPE/ choroid. HPA axis brake causes an imbalance of corticoid receptors expression in the RPE/choroid towards overactivation of MR pathway, which could favor the occurrence of CSCR.


Sujet(s)
Glucocorticoïdes/métabolisme , Minéralocorticoïdes/métabolisme , Rétine/métabolisme , Animaux , Choriorétinopathie séreuse centrale/traitement médicamenteux , Choriorétinopathie séreuse centrale/physiopathologie , Choroïde/effets des médicaments et des substances chimiques , Choroïde/métabolisme , Corticostérone/sang , Dexaméthasone/métabolisme , Dexaméthasone/pharmacologie , Oeil/métabolisme , Axe hypothalamohypophysaire/métabolisme , Phénomènes physiologiques oculaires/effets des médicaments et des substances chimiques , Axe hypophyso-surrénalien/métabolisme , Rats , Rats de lignée LEW , Récepteurs aux glucocorticoïdes/métabolisme , Rétine/effets des médicaments et des substances chimiques , Épithélium pigmentaire de la rétine/effets des médicaments et des substances chimiques , Épithélium pigmentaire de la rétine/métabolisme , Transduction du signal/génétique , Transduction du signal/physiologie
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...